GSK Advances mRNA Flu Shot to Phase 3 After Beating Standard Vaccines in Mid-Stage Trial — BigGo Finance
GSK is moving its experimental mRNA-based seasonal flu vaccine into a late-stage trial after mid-stage data showed it…
Browsing Tag